Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FH5EV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.90 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order, issued on September 10, 2025, represents a continuation of DMS Pharmaceutical Group's significant role in supplying pharmaceutical products to federal healthcare systems. The award carries no set-aside designation, allowing the woman-owned small business to compete directly in the open market. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will fulfill this order from its headquarters location.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. This comprehensive IDC enables the DLA to procure a broad range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. As a woman-owned small business pharmaceutical wholesaler registered in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent success in securing federal contracts and has established itself as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FH5EV?
SPE2DB25FH5EV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FH5EV worth?
The government has obligated $2,083 on SPE2DB25FH5EV.
Is contract SPE2DB25FH5EV an order under another contract?
Yes. SPE2DB25FH5EV is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5EV competed?
The extent of competition for SPE2DB25FH5EV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award